Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (USA) Facility
Date:1/31/2011

SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- Global Real Estate Consultants has helped Boehringer Ingelheim to strengthen their global presence with a new facility in Fremont.

Global Real Estate Consultants was retained by Boehringer Ingelheim to provide insight and transparency in the Fremont commercial real estate market specifically related to their purchase of Amgen Inc's 350,000 sq. ft. state-of-the-art manufacturing facility with pilot plant and process development labs. "We looked for an international tenant representation specialist to help us undertake a real estate acquisition in a new geographical area. We chose Global Real Estate Consultants because we felt that their level of expertise would best represent our interest," states Dr. Maier-Erbacher of Boehringer Ingelheim.

"We provided Boehringer Ingelheim with unrivaled objective information and transparency," says founder and company principal Erich Struzyk. "At the end we were able to provide savings for our client which they initially did not expect. Boehringer Ingelheim especially appreciated the fact that we do not represent landlords and thus avoided the typical conflicts of interest inherent in the brokerage market."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. For over 125 years, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development (http://www.boehringer-ingelheim.com).

About Global Real Estate Consultants

Global Real Estate Consultants (http://www.globalreconsultants.com) offers leading-edge corporate real estate advice, including portfolio, asset, location, transaction and workplace strategies. Global Real Estate Consultants leverages the expertise of global best-in-class resources, including consultants, economic development agencies, municipalities and other key components in order to provide an unrivaled, unbiased, and comprehensive solution. Global Real Estate Consultants has provided solutions that their clients were not able to obtain from any other provider at any price.


'/>"/>
SOURCE Global Real Estate Consultants
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
2. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
3. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
4. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
5. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
6. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
7. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
8. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
9. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
10. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
11. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... LODI, N.J. , Feb. 4, 2016  Montoya ... Pinnacle Professional in the field of Pharmaceuticals. Montoya is ... . ... and supplies, Becton Dickinson provides healthcare institutions, ... medical equipment throughout fifty countries across the globe. ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: OMCL ... solutions to healthcare systems, today announced results for its ... --> --> GAAP results: ... million, up $5.1 million or 4.1% from the third ... from the fourth quarter of 2014. Revenue for the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced that ... donate to Give To Cure’s campaign that is crowdfunding clinical trials to help find ... share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... At its ... of Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds ... of the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat ...
(Date:2/5/2016)... Francisco, CA (PRWEB) , ... February 05, 2016 ... ... and founder of CitiDent, announces that it is now welcoming orthodontist, ... Dr. Cheng, CitiDent offers a complete range of oral health care, including general ...
(Date:2/5/2016)... ... ... Health and wellness is a topic that should concern all Americans; however, it ... illness. Migraines are a severe form of a headache and often are accompanied by ... pain on their worst enemy, the feeling can last for many hours and be ...
(Date:2/5/2016)... ... February 05, 2016 , ... Calls Blacklist has just been ... user interface design and the developer has fixed known bugs within the app. Calls ... on their phone while not consuming any of their device’s battery power or memory. ...
Breaking Medicine News(10 mins):